Heart Test Laboratories (NASDAQ:HSCS) Stock Price Down 10.9% – Time to Sell?

Heart Test Laboratories, Inc. (NASDAQ:HSCS) shares were down 10.9% during mid-day trading on Thursday . The stock traded as low as $3.14 and last traded at $3.18. Approximately 34,292 shares changed hands during mid-day trading, a decline of 77% from the average daily volume of 152,124 shares. The stock had previously closed at $3.57.

Analyst Ratings Changes

Separately, Ascendiant Capital Markets reaffirmed a “buy” rating and issued a $15.00 price objective on shares of Heart Test Laboratories in a report on Monday, September 23rd.

Heart Test Laboratories Trading Down 10.9 %

The stock has a 50 day moving average of $3.54 and a 200 day moving average of $5.59. The company has a debt-to-equity ratio of 0.08, a current ratio of 4.49 and a quick ratio of 4.02. The firm has a market cap of $2.09 million, a P/E ratio of -0.07 and a beta of 3.16.

About Heart Test Laboratories

Heart Test Laboratories, Inc, a medical technology company, provides cardiovascular diagnostic devices. The company offers MyoVista wavECG, a resting 12-lead electrocardiograph (ECG) to provide diagnostic information related to cardiac dysfunction, as well as conventional ECG information. It serves clinics, doctor's offices, urgent care centers, and hospitals.